Molecular Imaging: Page 21

Hybrid imaging meeting attracts more than 2K attendees

By Kate Madden Yee

The Conference on Hybrid Imaging Live (CHILI 5.0) held virtually on 11 November attracted more than 2,000 attendees from 133 countries, according to its sponsor, the European Society for Hybrid, Molecular, and Translational Imaging (ESHIMT).

November 20, 2022

Dutch team evaluates bone formation in psoriatic arthritis patients

By Will Morton

Researchers from Amsterdam UMC have reported that F-18 sodium fluoride PET/CT may be a valuable tool for imaging patients with psoriatic arthritis because it reveals new bone formation missed on clinical evaluation of peripheral joints.

November 20, 2022

GE Healthcare invests 77M euros for contrast media production

By AuntMinnieEurope.com staff writers

GE Healthcare's Pharmaceutical Diagnostics business is investing $80 million (77 million euros) to increase manufacturing capacity by 30% at its Active Pharmaceutical Ingredients site in Lindesnes, Norway.

November 17, 2022

Where are we now with total-body PET/CT systems?

By Mélisande Rouger

New total-body PET/CT equipment could be a game changer in complex adult and pediatric cases, according to a Swiss nuclear medicine expert who has recently shared his experiences working with one of these scanners.

November 16, 2022

AuntMinnieEurope.com Molecular Imaging Insider

By Philip Ward

November 15, 2022

Much to gain from AI in hybrid imaging, but mind the gap

By Mélisande Rouger

Artificial intelligence (AI) can boost image quality and analysis and prediction in hybrid imaging, but clinicians must remain cautious with algorithms because they are not always reliable in clinical practice, a French expert in translational imaging has warned.

November 15, 2022

PET brings clarity and precision in cases of high-grade gliomas

By Philip Ward

A new French study has underlined the accuracy of F-18 fluorodopa-PET in differentiating recurrent malignant gliomas from treatment-related changes and shown the potential value of the dynamic slope as a diagnostic and prognostic biomarker.

November 15, 2022

PET/CT proves value in guiding breast cancer therapy

By Mélisande Rouger

FDG-PET/CT can help guide therapy in breast cancer, particularly in distant disease staging and treatment response assessment, the leading Austrian researcher Dr. Katja Pinker-Domenig told a hybrid imaging event on 11 November.

November 14, 2022

Reuters: Siemens seeks huge cost savings by restructuring

By AuntMinnieEurope.com staff writers

Siemens Healthineers said it plans to restructure its diagnostics division to save about $302 million (292 million euros) each year starting in 2025, according to a Reuters report.

November 13, 2022

Swiss team shows PET/CT's promise in malignant melanoma cases

By Will Morton

F-18 FDG-PET/CT imaging is a better choice than ultrasound for detecting both lymph node and abdominal metastases in patients with malignant melanoma, Swiss investigators have found.

November 13, 2022

Heidelberg group uses microscopy technique to map cancer cells

By Amerigo Allegretto

Investigators from the German Cancer Research Center have created a molecular microscopy technique that maps the spread of breast cancer at the cellular level. They published their findings on 9 November in Nature.

November 9, 2022

Blue Earth moves toward U.K. prostate radiopharmaceutical licensing

By AuntMinnieEurope.com staff writers

Blue Earth Therapeutics has secured an "innovation passport" from the U.K.'s Innovative Licensing and Access Pathway for its investigational therapeutic radiopharmaceutical lutetium-177 rhPSMA-10.1 for treatment of metastatic prostate cancer.

November 8, 2022

Previous Page

Page 21 of 121

Next Page